spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 1 November 2005
doi: 10.1242/jcs.02647


Journal of Cell Science 118, 5279-5289 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smalley, M. J.
Right arrow Articles by Dale, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smalley, M. J.
Right arrow Articles by Dale, T. C.

Dishevelled (Dvl-2) activates canonical Wnt signalling in the absence of cytoplasmic puncta

Matthew J. Smalley1, Nathalie Signoret2, David Robertson1, Alan Tilley3, Anthony Hann5, Ken Ewan5, Yanning Ding4, Hugh Paterson4 and Trevor C. Dale5,*

1 The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
2 MRC Cell Biology Unit-LMCB, University College London, Gower Street, London, WC1E 6BT, UK
3 Improvision, Viscount Centre II, University of Warwick Science Park, Milburn Hill Road, Coventry, CV4 7HS, UK
4 CRC Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
5 Cardiff School of Biosciences, Biomedical Sciences Building, Museum Avenue, Cardiff, CF10 3US, UK



View larger version (73K):

[in a new window]
 
Fig. 1. Localisation of ectopically expressed Dvl-2. (A-D) Localisation of transiently expressed HA-Dvl-2-EGFP (green) in HEK293 cells (A-B, nuclei counterstained with ToPro III), MDCK cells (C, nuclei counterstained with ToPro III) and CHO cells (D, no nuclear counterstain). (E-F) Localisation of transiently expressed HA-Dvl-2-ER (green) in MDCK cells. Cells were fixed 1 hour after re-feeding with medium containing ethanol vehicle (E) or 1 µM ß-estradiol (F). Bar, 15 µm.

 


View larger version (160K):

[in a new window]
 
Fig. 2. Localisation of activated HA-Dvl-2-ER protein in single-copy cell line. All images represent a projection of a series of stacked optical sections. Nuclei were stained with ToPro III (blue). Areas of colocalisation in overlaid images appear yellow. Cultures were treated with 1 µM ß-estradiol for 1 hour, fixed and stained, except as noted for panels G-I. (A-C) Colocalisation of F-actin and HA-Dvl-2-ER. F-actin is in red (A) and HA-Dvl-2-ER in green (B). Arrowheads in inset image indicate patches of HA staining projecting from the juxtamembrane region into cell interior. Arrowheads in the merged image (C) indicate examples of areas of colocalisation at the cell membrane. The complete series of optical sections is shown in supplementary material Fig. S3. (D-F) Colocalisation of {gamma}-tubulin and HA-Dvl-2-ER protein with {gamma}-tubulin in green (D) and HA-Dvl-2-ER in red (E). Arrows in merged image (F) indicate examples of co-staining at MTOC. (G-I) Disruption of membrane localisation of HA-Dvl2-ER protein by nocodazole treatment. Cells were treated with 33 µM nocodazole (a concentration which disrupts microtubule networks but not the MTOC) in DMSO for 3 hours and then with 1 µM ß-estradiol plus nocodazole for up to 1 hour. {gamma}-tubulin is in green (G) and HA-Dvl-2-ER in red (H). Arrows in merged image (I) indicate examples of co-staining at MTOC. Staining of control coverslips with an anti-{alpha}-tubulin antibody confirmed that microtubule networks were disrupted only in nocodazole-treated cultures and were not affected by the fixation protocol (data not shown). Similar disruption of HA-Dvl-2-ER at the membrane was seen in cells treated with nocodazole for periods of between 2 hours and 15 minutes (data not shown). Bars, 10 µm.

 


View larger version (26K):

[in a new window]
 
Fig. 3. Activation of canonical Wnt signalling by ectopic expression of Dvl-2 in high- and low-level expression systems. (A) HEK293 cells were transiently transfected (`high-level ectopic expression system') with either TCF-dependent transcription responsive (`canonical' Wnt signalling) reporter plasmids, reporter plasmids plus HA-Dvl-2 or reporter plasmids plus HA-Dvl-2-ER. Cultures were re-fed with medium containing 1 µM estradiol or control medium 24 hours prior to analysis for luciferase activity and protein levels in the detergent soluble and insoluble fractions of the cell extracts. (B) Time course of activation of canonical Wnt signalling pathway in Dvl-2-ER single-copy cell line. The cells were re-fed with medium containing 1 µM estradiol or with control medium and then harvested after 10, 30 and 60 minutes (10m/30m/60m) and 24 hours (24h) of induction. Detergent-soluble and -insoluble fractions were analysed by SDS-PAGE and western blotting. Identical protein levels were run on the gels. Blots were probed for the HA-tagged exogenous Dishevelled, for endogenous and exogenous Dvl-2 with a rabbit polyclonal anti-Dvl-2 and for endogenous ß-catenin and GSK-3ß. Note that although GSK-3ß levels remain constant, there was an increase in soluble ß-catenin levels from 30 minutes after ß-estradiol treatment. Also, note the disappearance of the endogenous Dvl-2 protein (anti-Dvl-2 probe, 98kD band) from the soluble fraction following ß-estradiol treatment, paralleling that of the single-copy fusion protein (150 kDa band). Finally, note the similarity in expression levels of the endogenous and exogenous proteins (estimated at three- to fivefold higher for the fusion protein). (C) Analysis of ß-catenin and endogenous Dvl-2 expression in the parental cell line after 60 minutes (60m) and 24 hours (24h) of ß-estradiol treatment. Note that there was no change in expression levels.

 


View larger version (90K):

[in a new window]
 
Fig. 4. Co-staining of HA-Dvl-2-EGFP with endocytic markers. (A-F) HEK293 cells immunostained with antibodies against endogenous EEA-1 (A,B), transferrin receptor (C,D) and CD63 (E,F). Antibody localisation is shown in red. There was no non-specific background staining when control isotype-specific antibodies was used as the primary antibody (data not shown). Nuclei were counterstained with ToPro III (blue). A,C,E, non-transfected cells. B,D,F, cells transfected with HA-Dvl-2-GFP. (G-H) Localisation of Alexa-594-coupled transferrin in HA-Dvl-2-GFP-transfected CHO cells, identifying peripheral transferrin-containing vesicles and early endosomes (G) or perinuclear recycling endosomes (H). (I) Localisation of late endosomes in HA-Dvl-2-GFP transfected CHO cells using an antibody to LgpB. Note that HA-Dvl-2-GFP failed to colocalise with any of these markers. (J) Analysis of HA-Dvl-2-GFP puncta using electron microscopy of HA-Dvl-2-GFP transfected HEK293 cells. The nuclear membrane (arrowheads) is clearly seen around the nucleus (n). In contrast, there is no evidence of a membrane around the electron-dense body (p), in which the HA-Dvl-2-GFP is concentrated, as shown by the anti-HA immuno-gold labelling in the magnified inset box (arrows). Bars, 5 µm (A-F); 20 µm (G-I); 1 µm (J).

 


View larger version (64K):

[in a new window]
 
Fig. 5. Domain dependence of Dvl-2 localisation in transient ectopic expression systems. (A-F) Immunolocalisation of HA-Dvl-2-ER proteins transiently transfected into MDCK cells. Cells were fixed 1 hour after re-feeding with medium containing 1 µM ß-estradiol or ethanol vehicle. (A) {Delta}DIX HA-Dvl-2-ER vehicle only. (B) {Delta}DIX HA-Dvl-2-ER treated with 1 µM estradiol. (C) {Delta}PDZ HA-Dvl-2-ER vehicle only. (D) {Delta}PDZ HA-Dvl-2-ER treated with 1 µM estradiol. (E) K446M HA-Dvl-2-ER vehicle only. (F) K446M HA-Dvl-2-ER treated with 1 µM estradiol. (G-J) Staining pattern of `actin mutant' and `vesicle mutant' Dvl-2 transfected into HEK293 cells. Dvl-2 localisation is in green and nuclei were counterstained with ToPro III (blue). (G) Wild-type HA-Dvl-2-EGFP. (H) HA-Dvl-2-EGFP K58A. (I,J) HA-Dvl-2-EGFP K68A,E69A. Bar, 8 µm.

 


View larger version (67K):

[in a new window]
 
Fig. 6. Domain dependence of Dvl-2-ER localisation in single-copy cell lines. All panels were stained with anti-HA antibody. (A) Parental HEK293 cells treated with vehicle only for 1 hour. (B) Parental HEK293 cells treated with 1 µM ß-estradiol for 1 hour. (C) Wild-type HA-Dvl-2-ER line vehicle-only control. (D) Wild-type HA-Dvl-2-ER line treated with 1 µM ß-estradiol for 1 hour. Inset is a close-up of HA-Dvl-2-ER localisation at MTOC (arrow) and at cell membranes (arrowheads). (E) {Delta}DIX HA-Dvl-2-ER line vehicle-only control. (F) {Delta}DIX HA-Dvl-2-ER line treated with ß-estradiol. Inset is a close-up of HA-Dvl-2-ER localisation at MTOC (arrow) and at cell membranes (arrowheads). (G) {Delta}PDZ HA-Dvl-2-ER line vehicle-only control. (H) {Delta}PDZ HA-Dvl-2-ER line treated with ß-estradiol. Note identical staining to control cells. (I) K446M HA-Dvl-2-ER line vehicle-only control. (J) K446M HA-Dvl-2-ER line treated with ß-estradiol. Inset is a close-up of HA-Dvl-2-ER localisation at MTOC (arrow) and at cell membranes (arrowheads). Bar, 40 µm.

 


View larger version (140K):

[in a new window]
 
Fig. 7. Time-lapse analysis of HA-Dvl-2-EGFP puncta. (A) Still frames from Movie 1B in supplementary material, illustrating lack of coordinated or directional movement in fluorescent bodies in a cell ectopically expressing HA-Dvl-2-EGFP at high levels. Frame numbers are indicated. Four bodies are false-coloured in the first frame (213) so that their fate may be followed. Note the yellow and green bodies fuse in frame 230 and the orange and red bodies fuse via a `dumb-bell' intermediate in frame 263. (B) Still frames from Movie 1C in supplementary material, illustrating lack of coordinated or directional movement in fluorescent bodies in a cell expressing lower levels of HA-Dvl-2-EGFP. Frame numbers are indicated. Two bodies are false coloured in the first frame (256) so that their fate may be followed. Note the red body appeared to split into two between frames 293 and 308, the yellow body disappeared by frame 314 and one of the two bodies resulting from the split of the red body disappeared by frame 328. Bars, 12 µm.

 





© The Company of Biologists Ltd 2005